A quiet but intense struggle is unfolding among major financial institutions over the tobacco giant Altria. The latest regulatory filings reveal a stark divide, with some asset managers building substantial positions while others are rapidly exiting. This fundamental disagreement on the company’s valuation is creating a uniquely volatile situation for its shares.
Institutional Investors Place Opposing Bets
Recent mandatory disclosures from December 2, 2025, highlight the dramatic split in institutional sentiment. On one side, Northwestern Mutual Wealth Management significantly increased its stake by 6.7 percent, bringing its total holding to approximately $15 million. This move represents a clear vote of confidence in the company’s long-term narrative.
Conversely, Gardner Russo & Quinn LLC executed a sharp reversal in the second quarter, slashing its position by more than 22 percent. The firm now retains about 191,000 shares, valued at just over $11 million. The contrasting strategies of these two heavyweight investors underscore the core dilemma facing the market: is Altria a deeply undervalued income stock, or a fading business propped up by financial engineering?
The Underlying Financial Tension
The company’s third-quarter results perfectly illustrate this conflict. Adjusted earnings per share rose by 3.6 percent to $1.45, surpassing analyst expectations. However, this positive headline figure masks a troubling trend.
Should investors sell immediately? Or is it worth buying Altria?
Revenue, excluding excise taxes, declined by 1.7 percent to $5.25 billion. To counter this organic shrinkage, Altria has relied on price increases and an aggressive share repurchase program, which recently removed 1.9 million shares from the market. These actions artificially boost per-share profitability but do not address the structural decline in the core business. The strategy of maintaining margins while volume erodes is the primary source of investor polarization.
Technical Indicators Flash a Warning
Adding to the fundamental debate is a concerning signal from the charts. As of December 2, the stochastic oscillator moved into overbought territory, a classic technical indicator that often precedes a price correction. The stock began the trading week at $58.98, notably below its 50-day moving average of $61.86. This price action suggests a lack of bullish momentum for a sustained upward move, indicating that new buyers may be entering during a period of short-term weakness.
The 2025 Outlook Hangs in the Balance
Management has provided full-year 2025 guidance for adjusted earnings per share in the range of $5.37 to $5.45. Achieving this target is heavily dependent on the company’s ability to continue offsetting falling shipment volumes with further price hikes.
The critical, unanswered question is how long this model can remain viable. Northwestern Mutual’s position appears to be a bet on the resilience of Altria’s dividend and a potential market undervaluation. Gardner Russo’s divestment suggests a loss of faith in that very premise. For investors, the outcome remains uncertain, making the upcoming quarterly results more decisive than ever.
Ad
Altria Stock: Buy or Sell?! New Altria Analysis from February 7 delivers the answer:
The latest Altria figures speak for themselves: Urgent action needed for Altria investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.
Altria: Buy or sell? Read more here...
